WebMay 1, 2024 · The regimen was well tolerated and a dose of venetoclax 800 mg was used for the phase 2 study. After the first cycle, the ORR in 53 patients was 90%. Based on DLBCL subtype by IHC, ORR and CR rate was 62% and 54% in non-GCB and 50% and 21% in GCB DLBCL. Notably, ORR was 40% with 30% CR in 10 patients who failed prior … WebJan 27, 2003 · RATIONALE: Less intensive therapy may attain in the same results as intensive therapy in children with non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to study the effectiveness of less intensive therapy for children who have non-Hodgkin's lymphoma.
Introduction of novel agents in the treatment of primary CNS …
WebJun 9, 2011 · These results were compared with those obtained with the CYVE regimen previously reported in two consecutive series of similar patients [2, 3]. Patients and … WebNov 15, 2007 · We aim to report the results of a phase II trial of the GEMOX‐R regimen in DLCL. The prognosis of old or immunocompromised patients with refractory or relapsing … palmat makeup brush cleaner
Chemotherapy regimen - Wikipedia
Web中枢神経系原発悪性リンパ腫は、リンパ節ではなく中枢神経（≒脳）に発生する節外性悪性リンパ腫です。眼球や脊髄など中枢神経系のどこにでも発生しますが、前頭葉、側頭葉、小脳、基底核、脳梁、脳室に多いようです。主な症状としては、精神症状（40％）や頭蓋内圧亢進症状（33%）が ... WebDec 7, 2024 · We retrospectively included patients over 60 years old and ineligible for HDT that received R-mini-CYVE regimen for R/R B-cell NHL between January 2009 and … WebMay 11, 2009 · The protocol consisted of an induction cytarabine–etoposide combination (the CYVE regimen) followed by high-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide (the TBC regimen). These results were recently confirmed in a multicenter phase II trial using the same regimen and including 43 patients . sunbreak bloom snow wail